Company profile
Salvina Therapeutics company profile
Salvina Therapeutics is working to break through efficacy barriers in inflammatory and autoimmune illnesses. The business discovered a novel epitope for specifically targeting TNF, culminating in the development of antibodies with a novel mode of action.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2023-05-01, Month
Headquarters
- Headquarters
- Allschwil, Basel-Landschaft, Switzerland
- Country code
- CH
- Continent
- Europe